Products 3751-02-8

CAS 3751-02-8 is the registry number for 5alpha-Dihydrocortisone 21-Acetate. Offered by: TRC. Available pack sizes: 100mg.

5alpha-Dihydrocortisone 21-Acetate
TRC
  • size: 100mg
  • Variants: 1
View product
Structural formula: {0} (CAS {1})

[2-(17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate (CAS 3751-02-8) is a chemical compound with the molecular formula C23H32O6 and a molecular weight of 404.5 g/mol. IUPAC name: [2-(17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate. InChIKey: AZCNJEFLSOQGST-UHFFFAOYSA-N.

Identity
Molecular formulaC23H32O6
Molecular weight404.5 g/mol
IUPAC name[2-(17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate
InChIKeyAZCNJEFLSOQGST-UHFFFAOYSA-N
SMILESCC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4C3(CCC(=O)C4)C)C)O

Computed by PubChem (NCBI)

Synonyms: 17-Hydroxy-3,11,20-trioxopregnan-21-yl acetate, 17,21-Dihydroxy-5alpha-pregnane-3,11,20-trione 21-acetate, 5.alpha.-Pregnane-3,20-trione, 17,21-dihydroxy-, 21-acetate, Pregnane-3,20-trione, 21-(acetyloxy)-17-hydroxy-, (5.alpha.)-, 5|A-Dihydrocortisone Acetate 21-Acetate, AZCNJEFLSOQGST-UHFFFAOYSA-N, 4,5-Dihydrocortisone, 21-acetate, 17-Hydroxy-3,11,20-trioxopregnan-21-yl acetate #, 5|A-Pregnan-17,21-diol-3,11,20-trione 21-acetate
Related forms of this compound
[2-[(5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H32O6
Isomers (same molecular formula)
(3R,6aS,11aS)-3,4a,7a-trihydroxy-10a-methyl-9-(5-oxo-2H-furan-3-yl)-2,3,4,5,6,6a,7,8,9,10,11,11a-dodecahydro-1H-cyclopenta[b]phenanthrene-11b-carbaldehyde C23H32O6
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H32O6
[2-[(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H32O6
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H32O6
[2-[(5R,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-5,6,7,8,9,11,12,14,15,16-decahydro-4H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H32O6
[(2R)-2-hydroxy-2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]ethyl] acetate C23H32O6
[2-oxo-2-[(8S,9S,10R,11S,13S,14S,17R)-9,11,12,12-tetradeuterio-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]ethyl] acetate C23H32O6
[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-3-oxo-2,7,8,8a-tetrahydro-1H-naphthalen-1-yl] (2S)-2-methylbutanoate C23H32O6